What Is The Buzz Surrounding Neovasc Inc (NASDAQ:NVCN)?

0
312

Fred Colen, the Chief Executive Officer and President of Neovasc Inc (NASDAQ:NVCN), presented at the LEERINK Partners 7th Yearly Global Healthcare Event on February 14 in New York City. As it is known, Neovasc marks as a specialty medical device firm that develops, manufactures and markets offerings for the cardiovascular marketplace. Its offering comprises the Neovasc Reducer™ targeting refractory angina. This product is not currently offered in the United States. Another product in the portfolio is the Tiara™, which is meant for the transcatheter cure of mitral valve ailment. As of now, Tiara is currently under clinical studies in the United States, Europe and Canada.

The buzz

Earlier in the month of January, Neovasc appointed Fred A. Colen as CEO and President of company, effective immediately. This change for brought about under the firm’s plan to boost its commercialization plans of its new-to-market Reducer™ product in Europe and the development of its Tiara™ mitral valve clinical plan.

Paul Geyer, the Chairman of Neovasc, expressed that the company has reached a vital turning point. They have performed a search for a pioneer with the skill and experience set to grow on the development recorded by Alexei Marko during his tenure as Chief Executive Officer. Colen is an experienced medical device executive with a remarkable reputation and track record as a strong leader. They consider he is exceptionally well qualified to direct Neovasc in its next stage of growth.

Colen expressed that grounded on a robust belief in the future of Neovasc’s products, he is excited to join the company’s team and to lead the firm at this thrilling time. He will start with a deep dive in different aspects of the firm, including its operations and products, in the imminent months, with the objective of determining the right plan to establish the most value for the firm’s different stakeholders. He expects working and coordinating with their investors, suppliers, employees and clients to grow commercial utilization and to offer the Tiara mitral valve to the customers.


THE HERALD FINANCE REPORT

Start your workday the right way with the news that matters most.

Your information is 100% secure with us and will never be shared
Disclaimer & Privacy Policy


LEAVE A REPLY

Please enter your comment!
Please enter your name here